Skip to main content
Erschienen in: Medical Oncology 4/2012

01.12.2012 | Original Paper

Hypofractionation in post-mastectomy breast cancer patients: seven-year follow-up

verfasst von: Hany Eldeeb, Iman Awad, Osman Elhanafy

Erschienen in: Medical Oncology | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

To compare three fractionation schedules in post-mastectomy patients treated with radiotherapy as regard acute and early late effects as well as local recurrence rates. One hundred and seven breast cancer patients treated with modified radical mastectomy and adjuvant radiotherapy ± adjuvant systemic treatments between November 2001 and July 2004 were enrolled in this study. Patients were categorized into three groups. Group A (41 patients) received conventional fractionation 50 Gy over 25 fractions. Group B (36 patients) received other fractionation regimen 45 Gy over 17 fractions. Group C (30 patients) received 40 Gy over 15 fractions. The median follow-up period was 23 months. There has been no statistical significant difference in local control (P = 0.88), pain (P = 0.98), telangectasis (P = 0.23), fibrosis (P = 0.13), arm oedema (P = 0.96) or pigmentation (P = 0.80) between the three groups. GII-III Erythema was significantly higher in the two hypofractionation arms compared to the control arm (P = 0.001). Although acute skin reactions were higher in the hypofractionated arms, there was no significant difference in the local recurrence rates or late radiation effects. A national randomized multicentre study is recommended to explore this further.
Literatur
1.
Zurück zum Zitat Bartelink H, Garavaglia G. Quality assurance in conservative treatment of early breast cancer. Report on a consensus meeting of the EORTC radiotherapy and breast cancer cooperative groups and the EUSOMA. Radiother Oncol. 1991;22:323–6.PubMedCrossRef Bartelink H, Garavaglia G. Quality assurance in conservative treatment of early breast cancer. Report on a consensus meeting of the EORTC radiotherapy and breast cancer cooperative groups and the EUSOMA. Radiother Oncol. 1991;22:323–6.PubMedCrossRef
2.
Zurück zum Zitat Morrow M, Strom E, Basset L, et al. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin. 2002;52:277–300.PubMedCrossRef Morrow M, Strom E, Basset L, et al. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin. 2002;52:277–300.PubMedCrossRef
3.
Zurück zum Zitat Voordeckers M, Vande Steene J, Vinh-Hung V, et al. Adjuvant radiotherapy after mastectomy for pT1-pT2 node negative(pN0) breast cancer: is it worth the effort? Radiother Oncol. 2003;68:227–31.PubMedCrossRef Voordeckers M, Vande Steene J, Vinh-Hung V, et al. Adjuvant radiotherapy after mastectomy for pT1-pT2 node negative(pN0) breast cancer: is it worth the effort? Radiother Oncol. 2003;68:227–31.PubMedCrossRef
4.
Zurück zum Zitat Johansson S, Sevensson H, Denekamp J. Time scale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Bio Phys. 2000;48:745–50.CrossRef Johansson S, Sevensson H, Denekamp J. Time scale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Bio Phys. 2000;48:745–50.CrossRef
5.
Zurück zum Zitat Whelan T, Marcellus D, Clarck R, et al. Adjuvant radiotherapy for early breast cancer: pattern of practice in Ontario. CAMAJ. 1993;149:1273–7. Whelan T, Marcellus D, Clarck R, et al. Adjuvant radiotherapy for early breast cancer: pattern of practice in Ontario. CAMAJ. 1993;149:1273–7.
6.
Zurück zum Zitat Yarnold J, Price P, Steel G. Non surgical management of early breast cancer in the United Kingdom: radiotherapy fractionation practices. Clinical Audit sub-committee of the Faculty of Clinical Oncology, Royal College of Radiologist, and the Joint Council for Clinical Oncology. Clin Oncol. 1995;7:223–6.CrossRef Yarnold J, Price P, Steel G. Non surgical management of early breast cancer in the United Kingdom: radiotherapy fractionation practices. Clinical Audit sub-committee of the Faculty of Clinical Oncology, Royal College of Radiologist, and the Joint Council for Clinical Oncology. Clin Oncol. 1995;7:223–6.CrossRef
7.
Zurück zum Zitat Priestman TJ, Bullimore JA, Godden TP, et al. The royal college of radiologist fractionation survey. Clin Oncol. 1989;11:39–46.CrossRef Priestman TJ, Bullimore JA, Godden TP, et al. The royal college of radiologist fractionation survey. Clin Oncol. 1989;11:39–46.CrossRef
8.
Zurück zum Zitat Clark RM, McCulloch PB, Levine MN, et al. Randomized clinic trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst. 1992;84:683–9.PubMedCrossRef Clark RM, McCulloch PB, Levine MN, et al. Randomized clinic trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst. 1992;84:683–9.PubMedCrossRef
9.
Zurück zum Zitat Clark RM, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. J Natl Cancer Inst. 1996;88:1659–64.PubMedCrossRef Clark RM, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. J Natl Cancer Inst. 1996;88:1659–64.PubMedCrossRef
10.
Zurück zum Zitat Whelan T, Mackenzie R, Julian J, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst. 2002;94:1143–50.PubMedCrossRef Whelan T, Mackenzie R, Julian J, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst. 2002;94:1143–50.PubMedCrossRef
11.
Zurück zum Zitat Ortholan C, Hannoun-Levi JM, Ferrero JM, et al. Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients. Int J Radiat Oncol Bio Phys. 2005;61:154–62.CrossRef Ortholan C, Hannoun-Levi JM, Ferrero JM, et al. Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients. Int J Radiat Oncol Bio Phys. 2005;61:154–62.CrossRef
12.
Zurück zum Zitat Bentzen SM, Agrawal RK, Aird EG, et al. The UK standardisation of breast radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;V371:1098–107. Bentzen SM, Agrawal RK, Aird EG, et al. The UK standardisation of breast radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;V371:1098–107.
13.
Zurück zum Zitat Shelley W, Brundage M, Hayter C, et al. A shorter fractionation schedule for post lumpectomy breast cancer patients. Int J Radiat Oncol Bio Phys. 2000;47:1219–28.CrossRef Shelley W, Brundage M, Hayter C, et al. A shorter fractionation schedule for post lumpectomy breast cancer patients. Int J Radiat Oncol Bio Phys. 2000;47:1219–28.CrossRef
14.
Zurück zum Zitat Rodger A. Fears over radiotherapy fractionation regimens in breast cancer. Proposed UK trial needs to define techniques as well as numbers of treatments. BMJ. 1998;317(7152):155–6.PubMedCrossRef Rodger A. Fears over radiotherapy fractionation regimens in breast cancer. Proposed UK trial needs to define techniques as well as numbers of treatments. BMJ. 1998;317(7152):155–6.PubMedCrossRef
15.
Zurück zum Zitat Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25 years follow-up. Int J Radiat Oncol Biol Phys. 1989;17:719–25.PubMedCrossRef Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25 years follow-up. Int J Radiat Oncol Biol Phys. 1989;17:719–25.PubMedCrossRef
16.
Zurück zum Zitat Kurtz JM, Jacquemier J, Amarlic R, et al. Risk factors for breast recurrence in pre menopausal and post menopausal patients with ductal cancer treated with breast conservation therapy. Cancer. 1990;65:1867–78.PubMedCrossRef Kurtz JM, Jacquemier J, Amarlic R, et al. Risk factors for breast recurrence in pre menopausal and post menopausal patients with ductal cancer treated with breast conservation therapy. Cancer. 1990;65:1867–78.PubMedCrossRef
17.
Zurück zum Zitat Touboul E, Buffat L, Belkacemi Y, et al. Local recurrence and breast metastasis after breast conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys. 1999;43:25–138.PubMedCrossRef Touboul E, Buffat L, Belkacemi Y, et al. Local recurrence and breast metastasis after breast conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys. 1999;43:25–138.PubMedCrossRef
18.
Zurück zum Zitat Wu JX, Hui ZG, Yu ZH. Post mastectomy radiotherapy with different fractionated dose schemes in early breast cancer (Abstract). Zhonghua zhong Liu Za Zhi. 2003;25:285–8.PubMed Wu JX, Hui ZG, Yu ZH. Post mastectomy radiotherapy with different fractionated dose schemes in early breast cancer (Abstract). Zhonghua zhong Liu Za Zhi. 2003;25:285–8.PubMed
19.
Zurück zum Zitat Goel A, Kaushal V, Hooda HS, et al. Comparison of two-radiation dose schedules in post mastectomy carcinoma of the breast. Indian J Med Sci. 2000;54:278–83.PubMed Goel A, Kaushal V, Hooda HS, et al. Comparison of two-radiation dose schedules in post mastectomy carcinoma of the breast. Indian J Med Sci. 2000;54:278–83.PubMed
20.
Zurück zum Zitat Whelan T. As presented at American College of Surgeons Oncology Group, Breast Section, Montreal, Canada, June 5, 2003. Whelan T. As presented at American College of Surgeons Oncology Group, Breast Section, Montreal, Canada, June 5, 2003.
21.
Zurück zum Zitat Olivotto IA, Weir LM, Kim-Sing C, et al. Late cosmetic results of short fractionation for breast conservation. Radiother Oncol. 1996;41:7–13.PubMed Olivotto IA, Weir LM, Kim-Sing C, et al. Late cosmetic results of short fractionation for breast conservation. Radiother Oncol. 1996;41:7–13.PubMed
22.
Zurück zum Zitat Yoshiya Y, Ida A, Edmee F, et al. Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer? Int J Radiat Oncol Bio Phys. 1999;44:99–104.CrossRef Yoshiya Y, Ida A, Edmee F, et al. Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer? Int J Radiat Oncol Bio Phys. 1999;44:99–104.CrossRef
23.
Zurück zum Zitat Lopez E, Guerrero R, Nunez M, et al. Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation induced DNA damage in lymphocytes. Breast Cancer Res. 2005;7:690–8.CrossRef Lopez E, Guerrero R, Nunez M, et al. Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation induced DNA damage in lymphocytes. Breast Cancer Res. 2005;7:690–8.CrossRef
24.
Zurück zum Zitat Spierer MM, Hong LX, Raouel T, et al. Post mastectomy CT-based electron beam radiotherapy: dosimetry, efficacy and toxicity in 118 patients. Int J Radiat Oncol Bio Phys. 2004;60:1182–9.CrossRef Spierer MM, Hong LX, Raouel T, et al. Post mastectomy CT-based electron beam radiotherapy: dosimetry, efficacy and toxicity in 118 patients. Int J Radiat Oncol Bio Phys. 2004;60:1182–9.CrossRef
25.
Zurück zum Zitat Rostom AY, Pradhan DG, White WF. Once weekly irradiation in breast cancer. Int J Radiat Oncol Biol Phys. 1987;13:551–5.PubMedCrossRef Rostom AY, Pradhan DG, White WF. Once weekly irradiation in breast cancer. Int J Radiat Oncol Biol Phys. 1987;13:551–5.PubMedCrossRef
26.
Zurück zum Zitat Taher A, El-Baradie M, Essa H, et al. Hypofractionation versus conventional fractionation radiotherapy after conservative treatment of breast cancer: early skin reactions and cosmetic results. J Egypt Nat Cancer Inst. 2004;16:178–87.PubMed Taher A, El-Baradie M, Essa H, et al. Hypofractionation versus conventional fractionation radiotherapy after conservative treatment of breast cancer: early skin reactions and cosmetic results. J Egypt Nat Cancer Inst. 2004;16:178–87.PubMed
27.
Zurück zum Zitat Shahid A, Athar MA, Asghar S, et al. Post mastectomy adjuvant radiotherapy in breast cancer: a comparison of three hypofractionated protocols. J Pak Med Assoc. 2009;59(5):282–7.PubMed Shahid A, Athar MA, Asghar S, et al. Post mastectomy adjuvant radiotherapy in breast cancer: a comparison of three hypofractionated protocols. J Pak Med Assoc. 2009;59(5):282–7.PubMed
28.
Zurück zum Zitat Marcenaro M, Sacco S, Pentimalli S, et al. Measures of late effects in conservative treatment of breast cancer with standard or hypofractionated radiotherapy. Tumori. 2004;90:586–91.PubMed Marcenaro M, Sacco S, Pentimalli S, et al. Measures of late effects in conservative treatment of breast cancer with standard or hypofractionated radiotherapy. Tumori. 2004;90:586–91.PubMed
29.
Zurück zum Zitat Romestaing P, Lehingue Y, Carrier C, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon. France J Clin Oncol. 1997;15:963–8. Romestaing P, Lehingue Y, Carrier C, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon. France J Clin Oncol. 1997;15:963–8.
30.
Zurück zum Zitat Hoeller U, Tribius S, Kuhlmey A, et al. Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores. Int J Radiat Oncol Biol Phys. 2003;55:1013–8.PubMedCrossRef Hoeller U, Tribius S, Kuhlmey A, et al. Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores. Int J Radiat Oncol Biol Phys. 2003;55:1013–8.PubMedCrossRef
31.
Zurück zum Zitat Hopwood P, Haviland JS, Georges Sumo G, et al. Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials. Lancet Oncol. 2010;11:231–40.PubMedCrossRef Hopwood P, Haviland JS, Georges Sumo G, et al. Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials. Lancet Oncol. 2010;11:231–40.PubMedCrossRef
32.
Zurück zum Zitat Dische S, Warburton MF, Jones D, et al. The recording of morbidity related to radiotherapy. Radiother Oncol. 1989;16:103–8.PubMedCrossRef Dische S, Warburton MF, Jones D, et al. The recording of morbidity related to radiotherapy. Radiother Oncol. 1989;16:103–8.PubMedCrossRef
33.
Zurück zum Zitat Baker MR, Bader D, Hopewell JW. The effects of single doses of X rays on the mechanical properties of pig skin in vivo. Br J Radiol. 1989;62:830–7.PubMedCrossRef Baker MR, Bader D, Hopewell JW. The effects of single doses of X rays on the mechanical properties of pig skin in vivo. Br J Radiol. 1989;62:830–7.PubMedCrossRef
34.
Zurück zum Zitat Warszawski A, Rottinger EM, Vogel R, et al. 20 MHz ultrasonic imaging for quantitative assessment and documentation of early and late post radiation skin reactions in breast cancer patients. Radiother Oncol. 1998;47:241–7.PubMedCrossRef Warszawski A, Rottinger EM, Vogel R, et al. 20 MHz ultrasonic imaging for quantitative assessment and documentation of early and late post radiation skin reactions in breast cancer patients. Radiother Oncol. 1998;47:241–7.PubMedCrossRef
35.
Zurück zum Zitat Russell NS, Knaken H, Bruinvis IA, et al. Quantification of patient to patient variation of skin erythema developing as a response to radiotherapy. Radiother Oncol. 1994;30:213–21.PubMedCrossRef Russell NS, Knaken H, Bruinvis IA, et al. Quantification of patient to patient variation of skin erythema developing as a response to radiotherapy. Radiother Oncol. 1994;30:213–21.PubMedCrossRef
36.
Zurück zum Zitat Gorodetsky R, Lotan C, Piggot K, et al. Late effects of dose fractionation on the mechanical properties of breast skin following post-lumpectomy radiotherapy. Int J Radiat Oncol Biol Phys. 1999;45:893–900.PubMedCrossRef Gorodetsky R, Lotan C, Piggot K, et al. Late effects of dose fractionation on the mechanical properties of breast skin following post-lumpectomy radiotherapy. Int J Radiat Oncol Biol Phys. 1999;45:893–900.PubMedCrossRef
Metadaten
Titel
Hypofractionation in post-mastectomy breast cancer patients: seven-year follow-up
verfasst von
Hany Eldeeb
Iman Awad
Osman Elhanafy
Publikationsdatum
01.12.2012
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 4/2012
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-012-0192-1

Weitere Artikel der Ausgabe 4/2012

Medical Oncology 4/2012 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.